Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00LNW
|
||||
| Former ID |
DIB005469
|
||||
| Drug Name |
KPT-330
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 2 | [524584] | ||
| Company |
Karyopharm therapeutics
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C17H11F6N7O
|
||||
| Canonical SMILES |
C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)<br />F)C(F)(F)F
|
||||
| InChI |
1S/C17H11F6N7O/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)15-26-9-30(29-15)4-1-14(31)28-27-13-8-24-2-3-25-13/h1-9H,(H,25,27)(H,28,31)/b4-1-
|
||||
| InChIKey |
DEVSOMFAQLZNKR-RJRFIUFISA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Drug Resistance Mutation (DRM) | |||||
| DRM | DRM Info | ||||
| Target and Pathway | |||||
| Target(s) | Exportin-1 | Target Info | Inhibitor | [544432] | |
| Pathway Interaction Database | Signaling events mediated by HDAC Class II | ||||
| Canonical NF-kappaB pathway | |||||
| Integrin-linked kinase signaling | |||||
| Signaling events mediated by HDAC Class I | |||||
| Role of Calcineurin-dependent NFAT signaling in lymphocytes | |||||
| FoxO family signaling | |||||
| Sumoylation by RanBP2 regulates transcriptional repression | |||||
| Hedgehog signaling events mediated by Gli proteins | |||||
| Regulation of nuclear beta catenin signaling and target gene transcription | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.